发明名称 |
composto, uso de um composto, métodos para a manutenção e para o tratamento de micobacterium tuberculose, formulação farmacêutica, e, terapia de combinação. |
摘要 |
(5R)-3-[4-[1-[(2S)-2,3-dihydroxypropanoyl]-3,6-dihydro-2H-pyridin-4-yl]-3,5-difluoro-phenyl]-5-(isoxazol-3-yloxymethyl)oxazolidin-2-one, or a pharmaceutically-acceptable salt, or an in-vivo-hydrolysable ester thereof, for use in the treatment of Mycobacterium tuberculosis. |
申请公布号 |
BRPI1009510(A2) |
申请公布日期 |
2016.03.15 |
申请号 |
BR2010PI09510 |
申请日期 |
2010.03.16 |
申请人 |
ASTRAZENECA AB |
发明人 |
DAS KAVERI;DAVID ALAN MELNICK;SHANDIL RADHA |
分类号 |
A61K45/06;A61K31/4439;A61P31/06 |
主分类号 |
A61K45/06 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|